ARCHIVES

Motesanib Does Not Improve OS; Study Doesn’t Meet Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 34 No. 4 | April 29, 2011

Download PDF Visit The Full Archive

Related Articles

Clinical Trials Approved In August 2002 By NCI

September 27, 2002

Funding opportunities listed.

November 12, 2004

FDA Oncology Division Director Says Goal to Make Review Process “Predictable”

August 2, 1996

Acupuncture Can Relieve Side Effects of Hormone Treatment

April 29, 2011

In Brief: Weissman Heads DCBD Board; Extra Money For Grants Lifts Funding Level To 35%

October 14, 1977

Former BMS Executive Bodnar Indicted.

April 25, 2008